Skip to main content
Watch Insiders
ELVNHealthcare

Enliven Therapeutics Inc (ELVN) Insider Trading

In the last 90 days, 4 Enliven Therapeutics Inc (ELVN) insiders reported no open-market purchases and 8 sales totaling $11,792,433. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 19, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 19, 2026Benjamin HohlCHIEF FINANCIAL OFFICERSale6,018$38.48$231,546
Oct 19, 2026Helen Louise CollinsCHIEF MEDICAL OFFICERSale5,000$38.47$192,342
Oct 1, 2026J. Scott GarlandDirectorSale13,000$46.67$606,719
Sep 17, 2026Benjamin HohlCHIEF FINANCIAL OFFICERSale6,018$50.35$303,003
Sep 17, 2026Helen Louise CollinsCHIEF MEDICAL OFFICERSale5,000$50.35$251,754
Aug 17, 2026Benjamin HohlCHIEF FINANCIAL OFFICERSale6,018$58.58$352,551
Aug 17, 2026Helen Louise CollinsCHIEF MEDICAL OFFICERSale5,000$58.59$292,931
Aug 4, 2026Mika K DerynckDirectorSale158,795$60.21$9,561,587
Jul 17, 2026Benjamin HohlCHIEF FINANCIAL OFFICERSale6,018$52.64$316,780
Jul 17, 2026Helen Louise CollinsCHIEF MEDICAL OFFICERSale5,000$52.67$263,374
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

ELVN insider trading FAQ

Are ELVN insiders buying or selling?
Over the last 90 days, ELVN insiders were net sellers, reporting $0.00 of open-market purchases and $11,792,433 of sales.
When was the last ELVN insider purchase?
No open-market insider purchase of Enliven Therapeutics Inc stock was reported in the last 90 days.
Where does ELVN insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Enliven Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.